Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 4687658013 | Azelastine- and fluticasone-containing product in nasal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core | 
| 4687659017 | Product containing azelastine and fluticasone in nasal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core | 
| 5301261000052116 | läkemedel som innehåller azelastin och flutikason, nasal läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Azelastine- and fluticasone-containing product in nasal dose form | Is a | Product containing azelastine and fluticasone (medicinal product) | true | Inferred relationship | Some | ||
| Azelastine- and fluticasone-containing product in nasal dose form | Is a | Fluticasone-containing product in nasal dose form | true | Inferred relationship | Some | ||
| Azelastine- and fluticasone-containing product in nasal dose form | Is a | Azelastine-containing product in nasal dose form | true | Inferred relationship | Some | ||
| Azelastine- and fluticasone-containing product in nasal dose form | Has manufactured dose form | Nasal dose form (dose form) | true | Inferred relationship | Some | ||
| Azelastine- and fluticasone-containing product in nasal dose form | Has active ingredient | Azelastine (substance) | true | Inferred relationship | Some | 1 | |
| Azelastine- and fluticasone-containing product in nasal dose form | Has active ingredient | Fluticasone (substance) | true | Inferred relationship | Some | 2 | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Azelastine and fluticasone only product in nasal dose form | Is a | True | Azelastine- and fluticasone-containing product in nasal dose form | Inferred relationship | Some | 
This concept is not in any reference sets